What is INBP's health score?

INTEGRATED BIOPHARMA INC (INBP) has a TradeApes health score of 48 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is INBP's estimated fair value?

Based on our 5-year discounted cash flow model, INTEGRATED BIOPHARMA INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is INBP undervalued or overvalued?

Our model currently rates INBP as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for INBP... Refresh in a moment for the full analysis.

INTEGRATED BIOPHARMA INC (INBP)

Healthcare Inconclusive inconclusive mixed

$0.18

Updated: 2026-06-06

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

40 Weak

Relative Value

65 Healthy

Capital Allocation

55 Mixed

Risk

80 Strong

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.